APA: Duloxetine Has Little Effect on Body Weight: Report on research findings announced at meeting in May 2002.
Cymbalta: Manufacturer's site for this selective serotonin and norepinephrine reuptake inhibitor (SSNRI), approved in the US to treat diabetic peripheral neuropathic pain and major depression.
Cymbalta: Full prescribing information from RxList.
Duloxetine Antidepressant Action Begins in One Week: Report on study findings announced in October 2002. [MedScape - Free registration required.]
Duloxetine for Major Depressive Disorder: A Randomized Double-Blind Placebo-Controlled Trial: Abstract of study findings published in April 2002.
Duloxetine: Lilly Receives Approvable Letter: News on FDA action in September 2002 related to the dual 5HT/noradrenaline reuptake inhibitor (also known as Cymbalta) for the treatment of depression.